Open innovation networks in Indian pharmaceutical sector

Bhawani Bhatnagar; Viktor Dörfler; Jillian MacBryde

Open innovation networks in Indian pharmaceutical sector

Bhawani Bhatnagar
, Viktor Dörfler
, Jillian MacBryde

Management Science

Research output: Contribution to conference › Paper › peer-review

255 Downloads (Pure)

Abstract

The Indian pharmaceutical sector grew spectacularly in a process patent regime, which enabled to entrench itself in the global market with generics and cost effective manufacturing processes. The legislative environment in India for the pharmaceutical sector underwent changes in 2005 leading to product patent protection. The sector was ready to embark on a smooth journey to path breaking innovation, equipped with enhanced process capabilities as well as expertise gained in modular aspects of drug innovation. Is innovation taking place in a manner as would have been expected?

The aim of this paper is to understand how the changes in patent regime have influenced the scientific innovation networks, through the lens of national innovation system and open innovation. This study examines an important and unexplored facet of open innovation and the findings may have important implications for organizations to further their innovation agenda.

Original language	English
Publication status	Published - 9 Sept 2015
Event	BAM 2015: The 29th Annual Conference of the British Academy of Management Conference - University of Portsmouth, Portsmouth, United Kingdom Duration: 8 Sept 2015 → 10 Sept 2015 http://www.bam.ac.uk/bam2015

Conference

Conference	BAM 2015: The 29th Annual Conference of the British Academy of Management Conference
Abbreviated title	BAM 2015
Country/Territory	United Kingdom
City	Portsmouth
Period	8/09/15 → 10/09/15
Internet address	http://www.bam.ac.uk/bam2015

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 9 Industry, Innovation, and Infrastructure

Keywords

patent protection
open innovation
Indian pharmaceutical sector
patent regime

Access to Document

Bhatnagar-etal-BAM2015-open-innovation-networks-in-indian-pharmaceutical-sectorAccepted author manuscript, 818 KB

Cite this

@conference{9af0d89e343446ba86e20adf37d59420,

title = "Open innovation networks in Indian pharmaceutical sector",

abstract = "The Indian pharmaceutical sector grew spectacularly in a process patent regime, which enabled to entrench itself in the global market with generics and cost effective manufacturing processes. The legislative environment in India for the pharmaceutical sector underwent changes in 2005 leading to product patent protection. The sector was ready to embark on a smooth journey to path breaking innovation, equipped with enhanced process capabilities as well as expertise gained in modular aspects of drug innovation. Is innovation taking place in a manner as would have been expected? The aim of this paper is to understand how the changes in patent regime have influenced the scientific innovation networks, through the lens of national innovation system and open innovation. This study examines an important and unexplored facet of open innovation and the findings may have important implications for organizations to further their innovation agenda.",

keywords = "patent protection, open innovation, Indian pharmaceutical sector, patent regime",

author = "Bhawani Bhatnagar and Viktor D{\"o}rfler and Jillian MacBryde",

year = "2015",

month = sep,

day = "9",

language = "English",

note = "BAM 2015: The 29th Annual Conference of the British Academy of Management Conference, BAM 2015 ; Conference date: 08-09-2015 Through 10-09-2015",

url = "http://www.bam.ac.uk/bam2015",

}

TY - CONF

T1 - Open innovation networks in Indian pharmaceutical sector

AU - Bhatnagar, Bhawani

AU - Dörfler, Viktor

AU - MacBryde, Jillian

PY - 2015/9/9

Y1 - 2015/9/9

N2 - The Indian pharmaceutical sector grew spectacularly in a process patent regime, which enabled to entrench itself in the global market with generics and cost effective manufacturing processes. The legislative environment in India for the pharmaceutical sector underwent changes in 2005 leading to product patent protection. The sector was ready to embark on a smooth journey to path breaking innovation, equipped with enhanced process capabilities as well as expertise gained in modular aspects of drug innovation. Is innovation taking place in a manner as would have been expected? The aim of this paper is to understand how the changes in patent regime have influenced the scientific innovation networks, through the lens of national innovation system and open innovation. This study examines an important and unexplored facet of open innovation and the findings may have important implications for organizations to further their innovation agenda.

AB - The Indian pharmaceutical sector grew spectacularly in a process patent regime, which enabled to entrench itself in the global market with generics and cost effective manufacturing processes. The legislative environment in India for the pharmaceutical sector underwent changes in 2005 leading to product patent protection. The sector was ready to embark on a smooth journey to path breaking innovation, equipped with enhanced process capabilities as well as expertise gained in modular aspects of drug innovation. Is innovation taking place in a manner as would have been expected? The aim of this paper is to understand how the changes in patent regime have influenced the scientific innovation networks, through the lens of national innovation system and open innovation. This study examines an important and unexplored facet of open innovation and the findings may have important implications for organizations to further their innovation agenda.

KW - patent protection

KW - open innovation

KW - Indian pharmaceutical sector

KW - patent regime

UR - http://www.bam.ac.uk/bam2015

M3 - Paper

T2 - BAM 2015: The 29th Annual Conference of the British Academy of Management Conference

Y2 - 8 September 2015 through 10 September 2015

ER -

Open innovation networks in Indian pharmaceutical sector

Abstract

Conference

UN SDGs

Keywords

Access to Document

Other files and links

Fingerprint

Navigating the open innovation paradox: an integrative framework for adopting open innovation in pharmaceutical R&D in developing countries

Cite this